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Distinction between dose addition and response addition for the
analysis of the toxicity of mixtures may allow differentiation of the
components regarding similar versus independent mode of action.
For nonlinear dose responses for the components, curves of dose
addition and response addition differ and embrace an ‘‘envelope of
additivity.’’ Synergistic or antagonistic interaction may then be
postulated only if the mixture effect is outside this surface. This
situation was analyzed for the induction of micronuclei in L5178Y
mouse lymphoma cells by the two methylating agents methyl
methanesulfonate (MMS) and N-methyl-N-nitrosourea (MNU)
and the topoisomerase-II inhibitor genistein (GEN). All three
chemicals reproducibly generated sublinear (upward convex)
dose-response relationships. For the analysis of mixture effects,
these genotoxic agents were investigated in the three binary
combinations. Statistical testing for dose addition along parallel
exponential dose responses was performed by linear regression
with interaction based on the logarithm of the number of cells
that contain micronuclei. For MMS+MNU, the mixture effect
was compatible with dose addition (i.e., significantly larger than
calculated for the addition of net responses). For MMS+GEN,
the measured effect was larger than for response addition but
smaller than for dose addition. For MNU+GEN, the measured
effect was below response addition, indicative of true antagonism.
In the absence of knowledge on the sublinear dose-response
relationships for the individual components, a synergistic effect
of MMS on both MNU and GEN would have been postulated
erroneously. The observed difference between MMS and MNU
when combined with GEN would not have been predicted on the
basis of a simplistic interpretation of DNA methylation as the
mode of action and may be due to differences in the profile of
DNA methylations and/or epigenetic effects. We conclude that
knowledge of nonlinearities of the dose-response curves of indi-
vidual components of a mixture can be crucial to analyze for syner-
gism or antagonism and that an in-depth mechanistic knowledge
is useful for a prediction of similarity or independence of action.
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A major objective of mixture testing is to establish whether
the toxicity of a combination of chemicals will deviate from an
effect expected for additivity. Bliss (1939) distinguished
between independent, similar, and synergistic action and
explained this on the basis of differences in modes of action.
For the analysis of results of mixture experiments, the re-
spective terms response addition, dose addition, and interaction
came into use (see review in Cassee et al., 1998). Response
addition is seen when the net effect of a mixture is equal to the
sum of the net effects of the components. For dose (or
concentration) addition, all chemicals in a mixture are
considered to act by the same mechanism, and the mixture
effect is determined by the sum of doses after adjustment for
differences in potency of the components. The U.S. EPA has
selected dose addition as the no-interaction definition for
mixture risk assessment, so that synergism would only stand
for effects that exceed those predicted for dose addition
(Hertzberg and MacDonell, 2002; Hertzberg and Teuschler,
2002). Using their definition, dose addition means that the
dose-response curves of the components are considered
identical except for dose scaling. If this requirement is met,
the components are often considered to act by a similar mode.
One critical aspect concerning dose addition and deviation
from additivity relates to the case of sublinear (upward convex)
dose-response relationships for the components, as illustrated
by Burkart and Jung (1998). Assume that dose x of chemical A
produces a response of 1 effect unit, and dose y of chemical B
has the same effect magnitude of 1. If under these conditions
a mixture of dose x of substance A plus dose y of substance B
generated effect level 4, one would on first sight postulate that
A and B acted in a synergistic manner. This interpretation is not
correct if both components A and B alone show a quadratic
dose response, which would result in effect level 4 with dose 2x
of A or dose 2y of B. Figure 1 is a graphical representation of
the necessity to distinguish between dose additivity and
response additivity under the conditions of sublinear dose-
response curves for the mixture components. The left-hand
panel shows a quadratic dose-response curve for both A and B.
The potency may differ, in that dose x of A is equivalent to dose
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y of B. The panel on the right-hand side shows two dose-
response curves and illustrates the dose response for B added to
dose x of A. Two curves are shown. The lower curve describes
the situation where B produces the response independent of
the process driven by A. The curve has the same shape as the
one on the left-hand side, except that it is set off on the y-axis
by response level 1. On this basis, y of B added to x of A would
result in effect level 2, as shown by the respective dashed line.
The upper curve describes the situation where B acts in the
same way as A. Addition of B results in moving up along the
curve shown in the left-hand panel, but the start is at response
level 1 and the slope is steeper, as given by the quadratic
function. For y of B added to x of A, this results in effect
level 4, but this is not a result of a synergistic interaction of
A and B. The two curves mark the boundary of the ‘‘envelope
of additivity,’’ and only outside the two curves can an
interaction be postulated as being synergistic or antagonistic.
While this issue is plausible conceptually, respective
observations are scarce (Doty et al., 1992; Mentzer et al.,
1999), and have, to our knowledge, not been corroborated
by specifically designed experiments. Here, we present and
analyze data of experiments that have been planned and
performed for this very purpose. They are based on the
induction of micronuclei in L5178Y mouse lymphoma cells
as an assay for genotoxicity of binary mixtures of compo-
nents that show sublinear dose-response relationships when
tested alone.
MATERIALS AND METHODS
In vitro micronucleus test. Mouse lymphoma L5178Y cells, clone 3.7.2c
(Clive et al., 1972) obtained from W.J. Caspary, NIEHS, were cultured in
suspension in RPMI 1640 cell culture medium supplemented with antibiotics,
0.25 mg L-glutamine/ml, 107 lg sodium pyruvate/ml, and 10% heat-
inactivated horse serum (all from Sigma, Taufkirchen, Germany). Cell cultures
were grown in a humidified atmosphere with 5% CO2 in air at 37C. The test
chemicals methyl methanesulfonate (MMS), N-methyl-N-nitrosourea (MNU),
and genistein (GEN) (all from Sigma) were dissolved in dimethylsulfoxide
(DMSO) and added to L5187Y mouse lymphoma cells at a density of 2 3 105
cells per ml (final DMSO concentration 1%). After 4 h of incubation, cells
were washed twice, and cytochalasin B was added to a final concentration of
5 lg/ml. Cytochalasin B remained in the culture for the entire expression time
of 20 h until the cells were harvested. Mouse lymphoma L5178Y cells tolerate
this treatment without showing nuclear extrusions or DNA fragmentation.
Cytospin preparations on glass slides were prepared. After 2 h in methanol at
20C, the slides were incubated with acridine orange (62.5 lg/ml in Sorensen
buffer, pH 6.8) for 5 min, washed twice with Sorensen buffer for 5 min, and
mounted for microscopy. Two thousand cells (1000 per slide) were evaluated
for each treatment. The score (MN) was the number of cells containing one or
more micronuclei per 1000 binucleated cells (BN cells). The percentage of
binucleated cells was evaluated as a marker of cell proliferation.
Dose selection. The concentration range used for the three chemicals was
defined by similar effect magnitude, in order not to exceed the response range
of the assay that may be limited by cytotoxicity. Based on pilot experiments, the
following concentration steps 0–1–2–3 were selected for the main experiments:
MMS: 0, 100, 200, 300 lM; MNU: 0, 700, 1400, 2100 lM; GEN: 0, 15, 30,
45 lM. Mixtures included the four possible combinations of low and medium
dose but not top concentrations, in order to keep the mixture effects within the
range covered by the dose responses of the components. Two completely
independent sets of experiments were run for each pairwise combination. In
addition, controls were run in duplicate. If the number of cells with micronuclei
observed in a combination exceeded the score of the top dose of either com-
ponent, the respective combination was not used for the test for dose addition.
Statistical analysis. The hypothesis of response addition (addition of net
effects of the components) was tested by the sign test. Under the null hypothesis
of response addition and the assumption of symmetrical errors, the observed
number of cells with micronuclei is with equal probability greater or less than
the number of cells with micronuclei calculated for response addition.
The hypothesis of dose addition was tested with a linear model, using the
logarithm of the score MN to linearize the sublinear dose responses for the
components in a parallel manner. For the test of deviation from dose addition,
we tested for interaction according to
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FIG. 1. Schematic representation of a nonlinear (here: quadratic) dose-response relationship (left-hand side; for A or B) and possibilities for the response to
a mixture of the two components (right-hand side; dose response for B added to dose x of A).
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Letters A and B stand for the concentrations of the two chemicals. A3B is
the interaction term. The coefficients a, b, c, and d were estimated by linear
regression. The error was proportional to the score MN. For the statistical
handling of the replicates, random effects for the parameters were added if this
resulted in a model improvement (mixed effects model).
Note: The absence of an interaction (d¼ 0) is equivalent to dose addition, as
can be shown by replacing B for A by normalization with c/b (last line):





In pilot studies with a number of genotoxic chemicals, we
found that the two methylating agents methyl methanesul-
fonate (MMS) and methylnitrosourea (MNU) and the
topoisomerase II-inhibitor genistein (GEN) reproducibly
produced sublinear (upward convex) dose-response relation-
ships for micronucleus induction in L5178Y mouse lym-
phoma cells. These genotoxic agents were selected for the
investigation of the combination effects of the binary
mixtures MMSþMNU, MMSþGEN, and MNUþGEN.
The cytochalasin B test modification was used. Cytochalasin
B inhibits the formation of two cells after nuclear division,
so that the cells are arrested in a binucleated state. This
limitation restricts the analysis to those cells that were able
to replicate DNA and go through nuclear division so that the
result is not biased by dose-related changes in the proportion
of cells going through the cell cycle within the period of
damage expression.
The panels on the left-hand side of Figure 2 show the
reproducibly sublinear dose-response curves for the induction
of micronuclei in four independent experiments. The degree of
nonlinearity was highest with MMS, lowest with MNU.
Logarithmic transformation of the response axis linearized
the curves (see right-hand panels in Fig. 2), which was the basis
for the use of a linear regression to test for interaction.
Numerical results of all experiments, including the binary
combinations MMSþMNU, MMSþGEN, and MNUþGEN,
are shown in Tables 1, 2, and 3, respectively. Columns 3 and
5 show the number of cells with micronuclei per 1000
binucleated cells. Columns 4 and 6 give the net treatment-
related increase by the components (lines 3–5 and 6–8) and the
result calculated for response addition (lines 9–12; mean of
controls plus the two corresponding net effects). Comparison
of the numbers in lines 9–12, columns 3 versus 4 and 5 versus
6 provides direct information whether the experimental result
is consistent with response addition following simple indepen-
dent action of the two components. Response addition was
rejected on the basis of the sign test for all binary combinations.
For the combination of MMSþMNU (Table 1) and MMSþGEN
(Table 2), the observed score was higher than the sum of net
effects; for the combination of MNUþGEN the mixture effect
was significantly below response addition (two-sided sign test:
8:0; p¼ 0.583 2¼ 0.008). In the absence of information on the
dose-response relationships of the components, one would have
postulated a synergistic effect of mixtures of MMSþMNU and
MMSþGEN and an antagonistic mixture effect of MNUþGEN.
For the analysis of the hypothesis of dose addition under the
assumption of parallel nonlinear dose-response curves, we
chose an exponential model based on the logarithms of the
response measures and tested for an interaction term of a linear
regression. For the combination MMSþMNU, the coefficient
d of the interaction term A3B was not significant (p ¼ 0.96),
so that our dose addition model could not be rejected. This also
means that the effect of a mixture of MMS and MNU could lie
on the curve of dose addition and may not be synergistic as
indicated by the test for response addition. This is indicated in
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FIG. 2. Shapes of the dose-response relationships observed for methyl
methanesulfonate (MMS), N-methyl-N-nitrosourea (MNU), and genistein
(GEN) for the induction of micronuclei in L5178Y mouse lymphoma cells.
Dose levels 0–3 stand for the following concentration steps: 0, 100, 200,
300 lM for MMS; 0, 700, 1400, 2100 lM for MNU; 0, 15, 30, 45 lM for GEN.
The panels on the right-hand side show that logarithmic transformation of the
y-axis obliterates the nonlinearity.
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three binary combinations. For the combination MMSþGEN,
the exponential model gave a highly significant negative
coefficient d of the interaction term (p¼ 4.63 106). Together
with the rejection of response addition (see above), this
combination effect is postulated to lie in the middle of the
envelope of additivity, significantly off both curves (Fig. 3). For
the combination MNUþGEN, antagonism had already been
shown for response addition. It is therefore not surprising that
testing for dose addition also produced a significant negative co-
efficient d of the interaction term (p¼ 5.43 106). In Figure 3,
this combination finds its position in the area of antagonism.
The percentage of binucleated cells as a measure for cytostatic
effects of the test substance showed a similar dose-dependent
decrease with MMS and MNU, from 82% in controls to 34
and 28% at the highest dose of MMS and MNU, respectively.
Genistein alone produced only a minor reduction (from 84 to
73%). The decrease seen upon combination of MMS or
MNU with genistein was dominated by the effect of the
methylating agent. Therefore, the difference between MMS
and MNU when combined with genistein cannot be due to
different percentages of binucleated cells.
DISCUSSION
We found three significantly different types of combination
effects for the induction of micronuclei by binary combinations
of the three genotoxic agents MMS, MNU, and genistein.
MMSþMNU was compatible with dose addition; MMSþGEN
was between dose addition and response addition; MNUþGEN
showed antagonism. In the absence of knowledge of the
sublinear dose response relationships for the individual
TABLE 1
Induction of Micronuclei in L5178Y Mouse Lymphoma Cells as
a Function of Concentration of Methyl Methanesulfonate (MMS),
N-Methyl-N-Nitrosourea (MNU), and Their Combination










0 0 16 — 11 —
0 0 16 — 13 —
100 0 29 13 26 14
200 0 52 36 88 76
300 0 160 144 210 198
0 700 51 35 50 38
0 1400 93 77 125 113





100 700 79 64 141 64
100 1400 131 106 256 139
200 700 200 87 230 126
200 1400 235b 129 253 201
aNumber of binucleated cells that show one or more micronuclei per 1000
binucleated cells.
bThe combination treatment 200 þ 1400 was not considered for the analysis
of dose addition because this score was higher than the range of scores covered
by the individual components.
TABLE 2
Induction of Micronuclei in L5178Y Mouse Lymphoma Cells as
a Function of Concentration of Methyl Methanesulfonate (MMS),
Genistein (GEN), and Their Combination










0 0 21 — 16 —
0 0 23 — 20 —
100 0 31 9 36 18
200 0 57 35 65 47
300 0 135 113 140 122
0 15 32 10 37 19
0 30 79 57 69 51





100 15 47 41 61 55
100 30 89 88 91 87
200 15 85 67 106 84
200 30 152 114 145 116
*Number of binucleated cells that show one or more micronuclei per 1000
binucleated cells.
TABLE 3
Induction of Micronuclei in L5178Y Mouse Lymphoma Cells as
a Function of the Concentration of N-Methyl-N-Nitrosourea
(MNU), Genistein (GEN), and Their Combination










0 0 24 — 25 —
0 0 24 — 27 —
700 0 82 58 73 47
1400 0 165 141 175 149
2100 0 279 255 302 276
0 15 77 53 76 50
0 30 120 96 131 105





700 15 74 135 114 123
700 30 138 178 112 178
1400 15 206 218 187 225
1400 30 224 261 258 280
*Number of binucleated cells that shows one or more micronuclei per 1000
binucleated cells.
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genotoxins, MMSþMNU and MMSþGEN would have been
misinterpreted to act in a synergistic manner. It illustrates that
an interpretation of mixture effects for a putative deviation from
additivity (synergism or antagonism) should include the eval-
uation of the dose-response relationship for the components.
This could be particularly important for endpoints related to
mutagenicity and carcinogenicity, where a linear-sublinear
shape of the dose-response curve can often be explained on
mechanistic grounds (Lutz, 1998).
Our analysis was based on an exponential model for the
description of the sublinear curves. It requires a minimum
number of parameters to be estimated, assumes an error that is
proportional to the response, and allows straightforward
calculation as a linear model, after logarithmic transformation
of the effect measure. However, using log(MN), the same
degree of nonlinearity is assumed for all three genotoxins,
although Figure 2 indicates some differences. Estimation of the
degree of nonlinearity by a nonlinear mixed-effects power
model fit by maximum likelihood using MN ~ a þ b 3 Ac
resulted in c ¼ 2.21 for MMS, 1.54 for MNU, and 1.72 for
GEN. Nevertheless, analysis of the mixture data with a power
model produced the same results as the exponential model
regarding the postulated difference between the three binary
combinations as shown schematically in Figure 3.
Using the exponential model, we assumed parallel dose-
response curves and used the definition given in the introduc-
tion. The literature also refers to dose addition in a more general
way (Berenbaum, 1989), as the method based on isoboles.
Isoboles have their particular value for the search for and
analysis of dose combinations that produce the same response
level. For a given response, isoboles can be used to analyze
combinations of agents irrespective of the shape of their dose-
response curves (Kortenkamp and Altenburger, 1998). Our
experiments included combinations at different dose levels (i.e.,
1 þ 1, 1 þ 2, 2 þ 1, 2 þ 2), which resulted in various response
levels. For this situation, our model was considered appropriate.
The differentiation between dose addition and response
addition has often been explained on mechanistic grounds. In
their review article, Cassee et al. (1998) define: ‘‘With dose
addition, each of the chemicals in the mixture contributes to the
toxicity of the mixture in proportion to its dose, expressed as
the percentage of the dose of that chemical alone that would be
required to obtain the given effect of the mixture. All chemicals
of concern in a mixture act in the same way, by the same
mechanisms, and differ only in their potencies.’’ The question
is whether this holds for MMS and MNU, for the combination
of which we could not reject dose addition. Both genotoxins
methylate DNA, so one could define DNA methylation as their
common mechanism. However, while the predominant site of
DNA methylation is the nitrogen atom at position 7 of guanine
for both genotoxins, there is a difference for the methylation at
less nucleophilic sites, such as O6 of guanine (Lawley, 1984).
With true dose addition, one would have to postulate that the
common reaction (i.e., guanyl-7-methylation) is primarily
responsible for the observed micronucleus induction. This is
a reasonable hypothesis, since this type of DNA methylation
destabilizes the N-glycosidic bond and facilitates depurination,
the repair of which is associated with strand breakage.
Following this interpretation, one would have to predict that
combination of either MMS or MNU with GEN should produce
the same type of mixture effect. This has not been found. While
MMSþGEN came to lie between dose addition and response
addition, MNUþGEN showed antagonism. Differences be-
tween MMS and MNU, for instance for DNA methylation as
mentioned above or for DNA synthesis inhibition (Slamenova
et al., 1990), did not result in deviation from dose addition, but
resulted in different combination effects with GEN. Note,
however, that failure to reject the null hypothesis of dose
addition is not equivalent with proof of this hypothesis, and that
similarity of a mode of action is not equivalent with full
mechanistic equality.
The type of a mixture effect may also be specific for a given
experimental system. The mouse lymphoma cells L5178Y
have a mutated p53 gene. Normal cells could react to DNA
damage in a different manner and show another response.
Combination effects may also differ between endpoints. While
we found an antagonistic mixture effect of MNUþGEN, it was
recently reported that genistein stimulated the growth of
mammary tumors that had been initiated with MNU (Allred
et al., 2004). Consideration of all these limitations is in line
with a recently published statement, based on several examples
from the pharmacological and toxicological literature, that
characteristics of a mixture can hardly be predicted from
knowledge on the components (Borgert et al., 2004). On the
other hand, our data illustrate that investigation of dose-
response relationships for individual components of a mixture
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FIG. 3. Conceptual representation of different mixture effects for the
induction of micronuclei in L5178Y mouse lymphoma cells by methyl
methanesulfonate (MMS), N-methyl-N-nitrosourea (MNU), and genistein
(GEN) in binary combinations. The assumption of dose addition was based
on parallel nonlinear dose-response curves for all components; response
addition was based on the sum of net effects.
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may help avoid misinterpretation of combination effects in
terms of synergism or antagonism in the absence of full
mechanistic information.
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